New Therapeutic Option for Patients with metastatic castration-resistant Prostate Cancer Talazoparib in combination with Enzalutamide prolongs progression-free Survival

被引：0
|
作者：
Ruedesheim, Sabine M.
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [21] Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
    El-Amm, Joelle
    Patel, Nihar
    Freeman, Ashley
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 235 - 245
  • [22] Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
    Baciarello, Giulia
    Sternberg, Cora N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 14 - 24
  • [23] Comparison of abiraterone and enzalutamide in patients with metastatic castration-resistant prostate cancer in Taiwan
    Ni, Hsueh Fen
    Li, Jian-Ri
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 60 - 60
  • [24] Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer
    Lin, Jianqing
    Elkon, Jacob
    Ricart, Brittany
    Palmer, Erica
    Zevallos-Delgado, Christian
    Noonepalle, Satish
    Burgess, Brooke
    Siegel, Robert
    Ma, Yan
    Villagra, Alejandro
    ONCOLOGIST, 2021, 26 (12): : E2136 - E2142
  • [25] COMBINATION OF INDOMETHACIN AND ENZALUTAMIDE TO TREAT CASTRATION-RESISTANT PROSTATE CANCER
    Liu, Chengfei
    Lou, Wei
    Pan, Chong-xian
    Lara, Primo
    Evans, Christopher
    Parikh, Mamta
    White, Ralph deVere
    Dall'Era, Marc
    Gao, Allen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E694 - E694
  • [26] Lutetium-PSMA therapy—a new therapeutic option in metastatic castration-resistant prostate cancer?
    Ladurner M.
    Horninger W.
    Bektic J.
    memo - Magazine of European Medical Oncology, 2018, 11 (4) : 301 - 304
  • [27] Enzalutamide for Patients with castration-resistant Prostate Cancer Comment
    Kretschmer, Alexander
    AKTUELLE UROLOGIE, 2020, 51 (01)
  • [28] Cabazitaxel multiple rechallenge in metastatic castration-resistant prostate cancer: A therapeutic option to increase overall survival?
    Pobel, Cedric
    Auclin, Edouard
    Teyssonneau, Diego
    Laguerre, Brigitte
    Cancel, Mathilde
    Boughalem, Elouen
    Noel, Johanna
    Brachet, Pierre Emmanuel
    Maillet, Denis
    Barthelemy, Philippe
    Helissey, Carole
    Thibault, Constance
    Oudard, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [29] Re: Enzalutamide and Survival in Nonmetastatic Castration-Resistant Prostate Cancer
    Mori, Keiichiro
    Egawa, Shin
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2021, 79 (03) : 430 - 431
  • [30] Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results
    Morris, Michael J.
    Molina, Arturo
    Small, Eric J.
    de Bono, Johann S.
    Logothetis, Christopher J.
    Fizazi, Karim
    de Souza, Paul
    Kantoff, Philip W.
    Higano, Celestia S.
    Li, Jinhui
    Thian Kheoh
    Larson, Steven M.
    Matheny, Shannon L.
    Naini, Vahid
    Burzykowski, Tomasz
    Griffin, Thomas W.
    Scher, Howard I.
    Ryan, Charles J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) : 1356 - +
12345